Nav: Home

New tool predicts risk of heart attack in older surgery patients

November 16, 2017

FINDINGS

A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery works significantly better than traditional risk assessment tools. By having more accurate information, older patients and their physicians can make an informed decision on whether to undergo surgery, UCLA researchers concluded.

BACKGROUND

In adults who undergo inpatient surgery, the mortality rate for those patients who experience cardiac arrest after surgery is 65 percent, and is about 15 to 25 percent for those who have a heart attack. Estimating the risk of cardiac complications is an important step in deciding if a person is healthy enough to undergo an operation. However, the current predictive tools are designed for patients of all ages and do not take into account the higher risks in older people.

METHOD

The researchers sought to develop a predictive tool that would be especially useful for patients 65 and older. It was based on the concept that older patients respond to risk factors differently than younger patients and these risk factors weigh differently across the age spectrum. Researchers tested this theory with existing tools and found they underestimated actual cardiac risk in older patients. They determined the accurate weight of each risk factor by age and selected the most important factors for this age group. The researchers then developed and tested the new risk predictive tool.

IMPACT

With a growing geriatric population and a projected increase in non-cardiac and elective surgeries, this tool, called the "Geriatric-Sensitive Perioperative Cardiac Risk Index," can offer accurate estimates of the cardiac risks for these patients. The researchers hope to improve the predictive models for older patients in future studies.
-end-
AUTHORS

Dr. Rami Alrezk led the study. Additional authors are Nicholas Jackson, Dr. Mohanad Al Rezk, Robert Elashoff, Dr. Nancy Weintraub, David Elashoff and Dr. Gregg Fonarow.

JOURNAL

The study was published Nov. 16 in the Journal of the American Heart Association.

FUNDING

This work was supported by the National Institutes of Health, National Center for Advancing Translational Sciences and the UCLA Clinical and Translational Science Institute. Alrezk's work is supported by the Office of Academic Affiliations, U.S. Department of Veterans Affairs. The authors have no financial interests to disclose.

University of California - Los Angeles Health Sciences

Related Heart Attack Articles:

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
Oxygen therapy for patients suffering from a heart attack does not prevent heart failure
Oxygen therapy does not prevent the development of heart failure.
I have had a heart attack. Do I need open heart surgery or a stent?
New advice on the choice between open heart surgery and inserting a stent via a catheter after a heart attack is launched today.
More Heart Attack News and Heart Attack Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.